IRON · NASDAQ · Biotechnology

Disc Medicine (IRON)

Develops heme and iron-homeostasis therapies for serious blood disorders.

$65.42
vs last close−3.06 (−4.47%)

Something off on this page? Send us feedback.

Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$1.65
Revenue estimate
$1.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported−$0.98−$1.02−$1.58−$1.77−$1.62−$1.65−$1.54Pending
Estimate−$1.06−$0.99−$1.17−$1.48−$1.69−$1.55−$1.71−$1.65
Surprise+7.5%−3.0%−35.0%−19.6%+4.1%−6.5%+9.9%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
ReportedPending
Estimate$150.0K$437.5K$1.0M$1.9M
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2027−$1.53
Sep 2027−$1.80
Jun 2027−$1.88
Mar 2027−$1.85
Dec 2026−$1.67
Nov 2026−$1.65
Jul 2026−$1.71−$1.54+9.9%
May 2026−$1.55−$1.65−6.5%
Feb 2026−$1.69−$1.62+4.1%
Nov 2025−$1.48−$1.77−19.6%
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Apr 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Jan 2021
Jun 2020
Mar 2020

The latest year is open to everyone — the 22 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2027−$1.53$23.5M
Sep 2027−$1.80$7.2M
Jun 2027−$1.88$580.0K
Mar 2027−$1.85$0
Dec 2026−$1.67$3.7M
Nov 5, 2026−$1.65$1.9M
Jul 30, 2026−$1.71−$1.54+9.9%$1.0M+7.5%
May 5, 2026−$1.55−$1.65−6.5%$437.5K−0.1%
Feb 26, 2026−$1.69−$1.62+4.1%$150.0K+1.5%
Nov 6, 2025−$1.48−$1.77−19.6%−1.5%
Aug 7, 2025
May 7, 2025
Feb 27, 2025
Nov 12, 2024
Aug 8, 2024
May 9, 2024
Mar 21, 2024
Nov 9, 2023
Aug 11, 2023
May 15, 2023
Apr 3, 2023
Nov 10, 2022
Aug 11, 2022
May 6, 2022
Mar 10, 2022
Nov 15, 2021
Aug 12, 2021
May 13, 2021
Mar 29, 2021
Jan 19, 2021
Jun 30, 2020
Mar 31, 2020

The latest year is open to everyone — the 22 quarters behind it read with an account.